Editorial Policy: How We Write, Check and Correct Articles

This policy covers the articles on the PlexusDx blog that end with a section headed "How we made this page". Those articles are drafted with AI tools from the sources each one lists, checked by separate AI reviewers and automated scripts, and approved by Jay Hastings, PlexusDx's CEO, before they are published. PlexusDx sells compounded GLP-1 treatment, so we have a financial interest in the topics we cover.

Dr. Asad K. Niazi, MD, MPH, reviews the articles' medical content, and his name appears on an article only after he has reviewed that version. PlexusDx's clinicians come from Lone Star Virtual Health, a company Dr. Niazi co-founded and leads, so he has a business relationship with PlexusDx. His review checks medical accuracy and safety. It is not an independent review.

An article's "How we made this page" section says how that article was made, which sources mattered most and when it was approved. A post without that section was not written under this policy. The rest of this page explains each step, how we handle these conflicts of interest, how we choose sources and show dates, and how to report an error.

We write for people deciding about GLP-1 treatment, with questions such as what it costs, whether insurance will pay, how compounded drugs are regulated and how to choose care safely. Each article starts from the questions readers ask about its topic and tries to answer them fully, including when the better choice for a reader is not PlexusDx.

Who is responsible

Publisher: PlexusDx, Inc. publishes the blog.
Writer: Jay Hastings, CEO of PlexusDx, is the named writer of every article and is responsible for what it says. He is not a clinician.
Medical reviewer: Dr. Asad K. Niazi, MD, MPH, reviews medical content. He is co-founder and CEO of Lone Star Virtual Health, the company that provides PlexusDx's clinicians. His page explains that relationship and lists his licenses and NPI.

Articles under this policy name no other writers or reviewers.

How we use AI

AI tools do most of the reading, drafting and checking. We use them because the answers to GLP-1 questions sit in many long documents that change over time: drug labels, insurers' coverage rules, government pages and companies' price terms. AI makes it practical to read and compare them all on one date.

We never treat what an AI tool writes as a source. Every statement in an article must trace to a document listed on the page or, for facts about PlexusDx, to our own records.

We also use AI-generated images in place of stock photos, and some of them show people. They are illustrations: we never present an AI-generated person as a real one, such as a doctor or a patient.

Research and drafting

An AI research assistant starts from the questions readers ask about the topic. It finds and reads the sources and records, for each fact, the source, the exact sentence that supports it and the date it was read. It also reads other pages on the same question, so the article can add what they leave out instead of repeating them.
An AI drafting assistant writes the article only from those records.

Separate AI reviews, covering six areas

The draft goes to AI reviewers who work separately, without seeing one another's notes, and look for reasons not to publish it. Depending on the article, a reviewer covers one of these areas or several of them:

Clinical accuracy: medical statements are supported by FDA prescribing information or published research, risks appear alongside benefits, and nothing could steer a reader away from care they need.
Fact-checking: each number, date, price, rule and quote is checked by opening its source.
Regulatory and legal risk: for example, compounded drugs are never presented as FDA-approved or the same as brand-name drugs, and every price shows its plan length and terms.
Helpfulness and originality: the article is written to help readers rather than to rank in search results, judged against Google's published guidance on helpful, people-first content.
Reader usefulness: the main question is answered at the top in plain language, with a real next step, including for readers who should not use PlexusDx.
PlexusDx facts: every statement about PlexusDx matches our current records.

An AI editor sorts the findings and revises the draft, and the draft is reviewed again until no reviewer reports a serious problem; the number of rounds differs from article to article. Then an AI reviewer that has not seen the earlier drafts or reviews reads the article and checks a sample of its claims against their sources, and any edits made after that reading are checked again. These AI reviews are not a medical or legal review.

Automated checks

Scripts check every draft before it can be approved. They:

confirm that every citation points to a listed source
confirm that links work and lead only to pages we allow
look for phrases on our banned list, such as calling a compounded drug "generic"
flag text repeated from older posts, from other sites' pages we read or from our other articles
measure the reading level and check that the article fits a phone screen

On most articles, scripts also compare each supporting quote with a saved copy of its source and redo any arithmetic, such as a year's total cost. Each article's "How we made this page" section says what was checked for that article.

What Jay and Dr. Niazi do

Jay Hastings confirms the statements about PlexusDx itself, reviews the final version of every article and approves it before it is published, or sends it back for changes. No article is published without his approval. Its "How we made this page" section gives the date he approved the current version.
Dr. Niazi reviews medical content: drug facts, safety information and other clinical statements. Every article goes to him, and his name appears on it only after he has reviewed that version and any changes he asked for have been made. The byline then says "Medically reviewed by Dr. Asad K. Niazi, MD, MPH, CEO of Lone Star Virtual Health, the company that provides PlexusDx's clinicians", and "How we made this page" gives the date of his review and states his business relationship with PlexusDx. An article without his name has not had his review.
Dr. Niazi does not review prices, insurance or tax rules, or PlexusDx's business terms. If we change an article's medical content after his review, his name comes off until he has reviewed the change. His page explains what his review line and date mean.

Sources we use

Every statement that comes from an outside source is linked to a numbered entry in the source list at the end of the article, with the date we read it. We use primary sources wherever they exist:

FDA prescribing information (drug labels) and FDA's own pages, including those on compounded drugs
government agencies and programs, such as NIH, CDC, CMS and Medicare, state Medicaid programs, the VA, TRICARE and the IRS
insurers' and pharmacy benefit managers' own coverage documents, drug lists and notices
drug manufacturers' own price pages and savings-program terms
peer-reviewed research, found through PubMed
other companies' own current pages, for facts about those companies

When we cannot open or find a primary source, we may use an authoritative summary, such as a health policy research group's summary of state laws, and the article says so. We do not use content farms, affiliate sites, AI-generated summaries or PlexusDx's older blog posts as sources. If we cannot confirm a fact in a source like these, we leave it out or say that we could not confirm it.

Statements about PlexusDx itself, such as what it offers and its terms, are our own statements, so they carry no outside citation. We check them against our live website and internal records, show the date of that check, and state nothing about PlexusDx that those records do not support. PlexusDx's refund and cancellation policy is a separate document. This page does not cover its terms.

Conflicts of interest and how we handle them

PlexusDx sells compounded GLP-1 treatment, so we have a financial interest in the topics we cover. Compounded drugs are not FDA-approved. As FDA explains on its page about unapproved GLP-1 drugs, the agency does not review them for safety, effectiveness or quality before they are sold. PlexusDx also offers genetic and blood tests.

Our medical reviewer has a business relationship with PlexusDx too. PlexusDx's clinicians, who decide whether to prescribe treatment for people who enroll through PlexusDx, come from Lone Star Virtual Health. Dr. Niazi co-founded Lone Star Virtual Health and is its chief executive officer. We never describe his review as independent, and we disclose this relationship wherever his review appears:

On every article that shows his review, the byline names him as CEO of Lone Star Virtual Health, the company that provides PlexusDx's clinicians.
That article's "How we made this page" section repeats that he leads Lone Star Virtual Health and says he has a business relationship with PlexusDx.
His own page explains the relationship at the top, and this policy states it here.

To keep these interests from shaping the facts in our articles:

Articles that discuss treatments, prices or providers state our interest near the top and again at the end.
They never call a compounded drug generic, FDA-approved or the same as a brand-name drug, and they never present brand-name drug trial results as results for compounded products.
When an FDA-approved drug, insurance coverage, Medicare or another program may suit a reader better, the article says so.
When an article lists what to check before choosing a provider, it answers the same questions about PlexusDx.
Facts about other companies come only from their own current pages, with the date we read them. Articles use other companies' names only to identify them and make no claims about their quality, safety or legality.
No provider is called "best" or "top" unless the article states its criteria and applies them to every provider, PlexusDx included.
No company pays to be included or mentioned, and we earn no commission from the links in our articles.
We do not claim to have used or tested other companies' services.

What we never do

In articles written under this policy, and on the pages about our writer and reviewer, we never:

invent people, such as writers, reviewers, clinicians, patients or staff
make up quotes, or attribute words or opinions to anyone, including Dr. Niazi, that are not their own
present an AI-generated image of a person as a real person, such as a doctor or a patient
put a physician's name on an article that physician has not reviewed
include testimonials, reviews, star ratings, patient stories, before-and-after claims or customers' health claims
claim testing, interviews or experiences that did not happen
give dosing, mixing or syringe-unit instructions; those come from your prescriber and your pharmacy label
change an article's date without changing what it says

Prices and dates

Prices, offers and coverage rules change often, so our articles show dates:

"As of" dates appear with prices and terms.
"Accessed" dates in the source list show when we read each source.
The "Updated" date in the byline shows the last time we changed what the article says. We do not change it just to make an article look new.
Approval and review dates in "How we made this page" show when Jay approved the current version and, once he has reviewed it, when Dr. Niazi reviewed its medical content.

We re-check the prices and offer terms in published articles every six months. When something has changed, we update the article and its date. A price can still change between our checks, so confirm it on the seller's own page before you pay.

Corrections

If you think something in an article is wrong or out of date, please tell us. Email info@plexusdx.com with the article's web address, the statement you think is wrong and, if you have one, a source.

We check the statement against its source. If the article is wrong, we correct it, update its date and add a short note at the end saying what we changed and when. A correction to medical content goes to Dr. Niazi, as described above.

This address is not for medical questions. For questions about your own health or treatment, contact your prescriber or your own doctor. In an emergency, call 911.

Information, not advice

Our articles are general information. They are not medical, legal or tax advice, and they cannot tell you whether a treatment is right for you. PlexusDx is not a medical practice or pharmacy, and using this website does not create a doctor-patient relationship between you and PlexusDx. Talk with your own clinician before you start, stop or change a treatment, ask your health plan about your coverage, and ask a tax professional about tax questions.

We drafted this policy with AI tools from our internal process documents. Jay Hastings approved this version on October 19, 2026. When the policy changes, we update this page and that date.